Alpha 2.0
Login Register
» Authors » C A M Marijnen

C A M Marijnen

Explore the profile of C A M Marijnen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 47
Citations 1816
Followers 0
Related Specialties
Oncology
General Surgery
Radiology
Top 10 Co-Authors
C J H van de Velde
H Putter
A M Stiggelbout
E Klein Kranenbarg
B Glimelius
H J Rutten
H J T Rutten
P J Tanis
I D Nagtegaal
A H Pieterse
Published In
Br J Surg
Eur J Surg Oncol
Eur J Cancer
ESMO Open
Radiother Oncol
Affiliations
Soon will be listed here.
Recent Articles
1.
Prospective radiotherapy quality Assurance leads to delineation guideline refinements for recurrent rectal cancer: Experience from the PelvEx II study
Piqeur F, Hupkens B, Creemers D, Nordkamp S, Berbee M, Buijsen J, et al.
Clin Transl Radiat Oncol . 2025 Mar; 52:100934. PMID: 40071235
Introduction: Target volume delineation in locally recurrent rectal cancer (LRRC) is clinically challenging. To ensure the quality of chemoradiotherapy (CRT) within the PelvEx II trial, a delineation guideline was developed...
2.
TNT for organ preservation in rectal cancer: still looking for the right schedule and patient
Grotenhuis B, Couwenberg A, Marijnen C
Ann Oncol . 2024 Oct; 35(11):928-929. PMID: 39461746
No abstract available.
3.
Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer
Piqeur F, Coolen L, Nordkamp S, Creemers D, Tijssen R, Neggers-Habraken A, et al.
Radiother Oncol . 2024 Sep; 200:110520. PMID: 39242031
Purpose: Substantiating data guiding clinical decision making in locally recurrent rectal cancer (LRRC) is lacking, specifically in target volume (TV) definition for chemoradiotherapy (CRT). A case-by-case review of local re-recurrences...
4.
Evolution of clinical nature, treatment and survival of locally recurrent rectal cancer: Comparative analysis of two national cross-sectional cohorts
van Geffen E, Langhout J, Hazen S, Sluckin T, van Dieren S, Beets G, et al.
Eur J Cancer . 2024 Mar; 202:114021. PMID: 38520925
Background: In the Netherlands, use of neoadjuvant radiotherapy for rectal cancer declined after guideline revision in 2014. This decline is thought to affect the clinical nature and treatability of locally...
5.
Corrigendum to "Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not": [ESMO Open 8 (2023) 101645]
Zwart W, Dijkstra E, Putter H, Marijnen C, Nilsson P, van de Velde C, et al.
ESMO Open . 2023 Oct; 8(6):102042. PMID: 37866027
No abstract available.
6.
Authors' reply-Does the RAPIDO trial suggest a benefit of post-operative chemotherapy after preoperative chemoradiation in rectal cancer? No, it does not
Zwart W, Dijkstra E, Putter H, Marijnen C, Nilsson P, van de Velde C, et al.
ESMO Open . 2023 Sep; 8(5):101645. PMID: 37713932
No abstract available.
7.
The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancer-results from the RAPIDO trial
Dijkstra E, Zwart W, Nilsson P, Putter H, Roodvoets A, Meershoek-Klein Kranenbarg E, et al.
ESMO Open . 2023 Mar; 8(2):101158. PMID: 36871393
Background: Pre-operative chemoradiotherapy (CRT) rather than radiotherapy (RT) has resulted in fewer locoregional recurrences (LRRs), but no decrease in distant metastasis (DM) rate for patients with locally advanced rectal cancer...
8.
Authors' reply-A sensitivity analysis of the RAPIDO clinical trial
Dijkstra E, Zwart W, Putter H, Marijnen C, Nilsson P, van de Velde C, et al.
Ann Oncol . 2022 Dec; 34(4):446-447. PMID: 36581138
No abstract available.
9.
Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)
van den Berg K, Schaap D, Voogt E, Buffart T, Verheul H, de Groot J, et al.
BMC Cancer . 2022 Sep; 22(1):957. PMID: 36068495
Background: The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been...
10.
The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer
Slevin F, Hanna C, Appelt A, Cunningham C, Marijnen C, Sebag-Montefiore D, et al.
Clin Oncol (R Coll Radiol) . 2021 Dec; 34(5):e210-e217. PMID: 34955376
Total mesorectal excision is the cornerstone of treatment for rectal cancer. Multiple randomised trials have shown a reduction in local recurrence rates with the addition of preoperative radiotherapy, either as...